Pioneering research has already shown that giving patients two medicines — aspirin and dipyridamole — can lower the risk of further stroke by thinning the blood to prevent the clots that can block blood flow to the brain.
Now researchers in the University’s Division of Stroke Medicine have been awarded £233,283 in funding by the British Heart Foundation (BHF) to study whether adding a third medicine called clopidogel is safe and even more effective than giving the two medicines alone.
The team, led by Professor Philip Bath, will study 350 stroke patients over a three year period — some of whom will be given the two usual medicines and some of whom will receive the new triple combination — to discover whether their recovery is improved by the inclusion of clopidogrel.
Professor Bath said: “Paraphrasing from Animal Farm, if 2 drugs are good then three might be better. If the trial is successful, the drugs are already available and could be introduced very soon and at very little extra cost.”
The research is just one project to be funded through a £3.5 million boost from the BHF for research into the causes, prevention, diagnosis and treatment of heart disease.
Professor Jeremy Pearson, Associate Medical Director at the BHF said: “Thanks to the generous support from fundraisers and volunteers in the East Midlands, we can invest in this top notch heart research.”
“Each project solves a piece of the puzzle of heart and circulatory disease. We urge people to continue donating time and money so that we can find solutions for prevention, diagnosis and treatment of the UK’s biggest killer.”
Emma Thorne | alfa
Purdue cancer identity technology makes it easier to find a tumor's 'address'
16.11.2018 | Purdue University
Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University
Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.
Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...
Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.
Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
09.11.2018 | Event News
06.11.2018 | Event News
23.10.2018 | Event News
16.11.2018 | Health and Medicine
16.11.2018 | Life Sciences
16.11.2018 | Life Sciences